• AAPL 192.845
  • TSLA 239.33
  • AMZN 145.945
  • BTC-USD 40819.7266
  • ETH-USD 2186.0203
  • EURUSD 1.0766
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. BPMUF.US

Basilea Pharmaceutica AG (BPMUF PINK) stock market data APIs

$41 0(0%) as of December 8, 2023

Basilea Pharmaceutica AG Financial Data Overview

41
41
-
41
41
41-52
491 M
8.0392
11 980 K
175 M
-0.9943
0
0.726
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BPMUF',
Type: 'Common Stock',
Name: 'Basilea Pharmaceutica AG',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000KPT5K6',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
GicSector: NULL,
GicGroup: NULL,
GicIndustry: NULL,
GicSubIndustry: NULL,
HomeCategory: NULL,
IsDelisted: false,
}

Basilea Pharmaceutica AG Fundamental Data is available in our Financial Data APIs

  • Net Revenue 175 M
  • EBITDA 69 182 K
  • Earnings Per Share 5.1
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Basilea Pharmaceutica AG Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Basilea Pharmaceutica AG End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Basilea Pharmaceutica AG latest news via APIs

Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis

Basilea Pharmaceutica AG Allschwil, Switzerland, December 11, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of pa...

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year

Basilea Pharmaceutica AG Allschwil, Switzerland, November 20, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of pa...
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com